Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Urology|November 16, 2020
T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at DiagnosisFlorus C de Jong, Robert F Hoedemaeker, Vebjørn Kvikstad, et al.
Urologic Oncology|March 13, 2024
Alignment of molecular subtypes across multiple bladder cancer subtyping classifiersMoritz J Reike, Joep J de Jong, Tarek A Bismar, et al.
World Journal of Urology|January 3, 2025
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCGFlorus C de Jong, Vebjørn Kvikstad, Robert F Hoedemaeker, et al.
European Urology|March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
European Urology Oncology|April 29, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort AnalysisDebbie G J Robbrecht, Youssra Salhi, John W M Martens, et al.
European Urology Oncology|November 11, 2023
Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines OfficeJoost L Boormans, Richard Sylvester, Lynn Anson-Cartwright, et al.
BJU International|January 6, 2021
Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancerAnke Richters, Theodora M Ripping, Lambertus A Kiemeney, et al.
European Urology Open Science|May 9, 2022
A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily PracticeBen-Max de Ruiter, Maaike W van de Kamp, Jonah P Z van Steenbergen, et al.
The Journal of Urology|January 4, 2017
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter StudyWillemien Beukers, Kirstin A van der Keur, Raju Kandimalla, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2016
Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based studyTom J N Hermans, Elisabeth E Fransen van de Putte, Simon Horenblas, et al.
Pageof 11